These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10785838)

  • 21. [Human supplementary motor area: a role in voluntary movements and its clinical significance].
    Ikeda A
    Rinsho Shinkeigaku; 2007 Jan; 47(1):8-20. PubMed ID: 17491331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
    Castillo JL; Miranda CM; Araya F; Sáez D
    Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
    Lefaucheur JP
    Clin Neurophysiol; 2005 Feb; 116(2):244-53. PubMed ID: 15661100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensorimotor integration in movement disorders.
    Abbruzzese G; Berardelli A
    Mov Disord; 2003 Mar; 18(3):231-240. PubMed ID: 12621626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repetitive transcranial magnetic stimulation applied over the premotor cortex on somatosensory-evoked potentials and regional cerebral blood flow.
    Urushihara R; Murase N; Rothwell JC; Harada M; Hosono Y; Asanuma K; Shimazu H; Nakamura K; Chikahisa S; Kitaoka K; Sei H; Morita Y; Kaji R
    Neuroimage; 2006 Jun; 31(2):699-709. PubMed ID: 16466934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
    Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
    Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine agonist-based strategies in the treatment of Parkinson's disease.
    Antonini A; Barone P
    Neurol Sci; 2008 Dec; 29 Suppl 5():S371-4. PubMed ID: 19381765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of L-dopa on event-related desynchronization in Parkinson's disease.
    Magnani G; Cursi M; Leocani L; Volonté MA; Comi G
    Neurol Sci; 2002 Sep; 23(3):91-7. PubMed ID: 12391492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive autoregressive identification with spectral power decomposition for studying movement-related activity in scalp EEG signals and basal ganglia local field potentials.
    Foffani G; Bianchi AM; Priori A; Baselli G
    J Neural Eng; 2004 Sep; 1(3):165-73. PubMed ID: 15876636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The abnormality of N30 somatosensory evoked potential in idiopathic Parkinson's disease is unrelated to disease stage or clinical scores and insensitive to dopamine manipulations.
    Onofrj M; Fulgente T; Malatesta G; Ferracci F; Thomas A; Curatola L; Bollettini F; Ragno M
    Mov Disord; 1995 Jan; 10(1):71-80. PubMed ID: 7885358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder.
    Rossi S; Bartalini S; Ulivelli M; Mantovani A; Di Muro A; Goracci A; Castrogiovanni P; Battistini N; Passero S
    Biol Psychiatry; 2005 Jan; 57(1):16-20. PubMed ID: 15607295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Movement characteristics in Parkinson's disease: determination of dopaminergic responsiveness and threshold.
    van Hilten JJ; Wagemans EA; Ghafoerkhan SF; van Laar T
    Clin Neuropharmacol; 1997 Oct; 20(5):402-8. PubMed ID: 9331516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease.
    Perrotta A; Serrao M; Bartolo M; Valletta L; Locuratolo N; Pujia F; Fattapposta F; Bramanti P; Amabile GA; Pierelli F; Parisi L
    Clin Neurophysiol; 2005 Sep; 116(9):2091-8. PubMed ID: 16029959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal organization of cerebral events: neuromagnetic studies of the sensorimotor system.
    Forss N; Silén T
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):816-21. PubMed ID: 11677402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generators and temporal succession of giant somatosensory evoked potentials in cortical reflex myoclonus: epicortical recording from sensorimotor cortex.
    Hitomi T; Ikeda A; Matsumoto R; Kinoshita M; Taki J; Usui K; Mikuni N; Nagamine T; Hashimoto N; Shibasaki H; Takahashi R
    Clin Neurophysiol; 2006 Jul; 117(7):1481-6. PubMed ID: 16759904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia.
    Margari L; de Mari M; Lamberti P; Iliceto G; Serlenga L; Perniola T; Rossini PM; Ferrari E
    Funct Neurol; 1995; 10(2):99-105. PubMed ID: 7557558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.